CV Sciences (CVSI) Total Debt Growth (3y) (2016 - 2025)
CV Sciences (CVSI) Total Debt Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 15.43% |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -7.08% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 11.33% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -3.67% |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -10.43% |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -13.72% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 92.83% |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.49% |
| Jun 30, 2025 | -10.64% |
| Mar 31, 2025 | -9.75% |
| Dec 31, 2024 | -4.24% |
| Mar 31, 2021 | -32.36% |
| Sep 30, 2020 | 30.71% |
| Jun 30, 2020 | 29.10% |
| Dec 31, 2016 | -47.31% |
| Sep 30, 2016 | -14.96% |
| Jun 30, 2016 | -11.01% |
| Mar 31, 2016 | -9.12% |